Multimillion-dollar drug yanked from market connected to dangerous brain inflammation cases in U.S.

The FDA is reviewing whether a type of brain inflammation called encephalitis linked to Biogen and AbbVie’s MS drug Zinbryta was a result of a known side effect of the therapy or has another cause, a FDA spokesperson told MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.